— Know what they know.
Not Investment Advice
Also trades as: ALL-PH (NYSE) · $vol 2M · ALL-PG (NYSE) · $vol 2M · ALL-PJ (NYSE) · $vol 1M · ALL-PB (NYSE) · $vol 1M · ALL-PI (NYSE) · $vol 1M · 0HCZ.L (LSE) · $vol 0M · ALS.DE (XETRA) · $vol 0M

ALL NYSE

The Allstate Corporation
1W: -1.7% 1M: -13.7% 3M: -9.9% YTD: +10.3% 1Y: +6.7% 3Y: +107.4% 5Y: +90.2%
$223.74
-0.67 (-0.30%)
 
Weekly Expected Move ±3.6%
$208 $216 $224 $232 $240
NYSE · Financial Services · Insurance - Property & Casualty · Tech Score Sell · Power 37 · $57.6B mcap · 256M float · 0.735% daily turnover · Short 28% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
50.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 37.9%  ·  5Y Avg: 12.9%
Cost Advantage
52
Intangibles
40
Switching Cost
52
Network Effect
50
Scale ★
66
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ALL shows a Weak competitive edge (50.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 37.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$226
Low
$272
Avg Target
$315
High
Based on 11 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 17Hold: 23Sell: 4Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$267.71
Analysts21
Consensus Change History
DateFieldFromTo
2026-06-09 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-01 Goldman Sachs — $280 $250 -30 +12.7% $221.86
2026-09-18 Mizuho Securities — $297 $300 +3 +18.9% $252.21
2026-09-16 Mizuho Securities — $272 $297 +25 +15.5% $257.21
2026-08-28 Argus Research Kevin Heal $155 $238 +83 -7.6% $257.62
2026-08-11 Morgan Stanley — $240 $265 +25 -1.0% $267.77
2026-08-11 Raymond James — $300 $315 +15 +18.3% $266.31
2026-08-10 UBS — $261 $275 +14 +1.4% $271.07
2026-08-07 Goldman Sachs Robert Cox $238 $280 +42 +1.8% $275.11
2026-08-07 Wells Fargo — $228 $250 +22 -9.1% $275.11
2026-08-06 Roth Capital — $275 $300 +25 +13.4% $264.59
2026-08-06 Barclays Alex Scott $213 $226 +13 -14.6% $264.59
2026-07-17 Roth Capital — $240 $275 +35 +10.6% $248.55
2026-07-15 Atlantic Equities — Initiated $319 — +32.6% $240.55
2026-07-14 UBS — $250 $261 +11 +4.3% $250.35
2026-07-10 Evercore ISI David Motemaden $225 $240 +15 -4.2% $250.59
2026-07-09 Cantor Fitzgerald Ryan Tunis Initiated $242 — -2.9% $249.27
2026-07-09 Mizuho Securities — $281 $272 -9 +8.3% $251.17
2026-07-07 Barclays Alex Scott $198 $213 +15 -14.2% $248.37
2026-07-06 Raymond James — $260 $300 +40 +20.9% $248.04
2026-07-06 Morgan Stanley Bob Huang $215 $240 +25 -4.1% $250.33
2026-07-06 HSBC Vikram Gandhi $190 $264 +74 +5.5% $250.33
2026-05-01 Piper Sandler — $196 $268 +72 +23.4% $217.26
2026-03-03 Raymond James Gregory Peters $250 $260 +10 +21.7% $213.61
2026-02-09 Mizuho Securities — $255 $281 +26 +35.4% $207.55
2026-02-06 Goldman Sachs — $227 $238 +11 +14.7% $207.55
2026-02-06 Wells Fargo Elyse Greenspan $223 $228 +5 +7.5% $212.13
2026-01-14 Mizuho Securities — $254 $255 +1 +29.0% $197.65
2026-01-13 Wells Fargo — $202 $223 +21 +6.9% $208.66
2026-01-07 Goldman Sachs — $166 $227 +61 +9.5% $207.27
2026-01-07 Evercore ISI — $233 $225 -8 +7.7% $208.97
2025-12-16 Morgan Stanley Bob Huang $137 $215 +78 +1.6% $211.69
2025-12-15 Mizuho Securities Yaron Kinar Initiated $254 — +20.0% $211.69
2025-11-26 Roth Capital Harry Fong $230 $240 +10 +12.9% $212.65
2025-10-08 UBS — Initiated $250 — +17.3% $213.06
2025-10-01 Evercore ISI David Motemaden $138 $233 +95 +8.5% $214.65
2025-09-26 Roth Capital — Initiated $230 — +9.6% $209.82
2025-08-05 Wells Fargo — $197 $202 +5 -1.7% $205.55
2025-07-31 Barclays Alex Scott $119 $198 +79 +3.0% $192.28
2025-05-06 Wells Fargo Elyse Greenspan $187 $197 +10 -1.6% $200.17
2025-05-05 Raymond James Gregory Peters $220 $250 +30 +24.8% $200.25
2025-01-14 Wells Fargo Elyse Greenspan $175 $187 +12 +0.5% $186.04
2024-10-18 BMO Capital Michael Zaremski $205 $214 +9 +9.5% $195.51
2024-10-18 Bank of America Securities Joshua Shanker $216 $233 +17 +19.2% $195.51
2024-10-10 Bank of America Securities Joshua Shanker Initiated $216 — +16.8% $184.91
2024-10-04 Raymond James Gregory Peters $165 $220 +55 +17.1% $187.84
2024-08-16 Wells Fargo Elyse Greenspan $177 $175 -2 -1.7% $178.11
2024-08-16 Piper Sandler Paul Newsome $188 $196 +8 +10.0% $178.11
2024-08-14 CFRA Catherine Seifert Initiated $200 — +10.5% $180.95
2024-08-12 Wells Fargo Elyse Greenspan $104 $177 +73 +3.5% $171.03
2024-08-05 Jefferies Yaron Kinar $122 $217 +95 +28.4% $169.02

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 02, 2026
DCF
5
ROE
5
ROA
5
D/E
2
P/E
4
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ALL receives an overall rating of A. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5), P/E (4/5). Areas of concern: D/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-07 A- A
2026-08-06 A A-
2026-07-22 A+ A
2026-07-01 A A+
2026-05-01 A- A
2026-04-29 A A-
2026-02-19 C+ A
2026-02-10 A C+
2026-01-26 A+ A
2026-01-03 A- A+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 60 Grade A
Profitability
69
Balance Sheet
63
Earnings Quality
73
Growth
65
Value
79
Momentum
78
Safety
100
Cash Flow
79
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ALL scores highest in Safety (100/100) and lowest in Balance Sheet (63/100). An overall grade of A places ALL among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman-I Score
11.39
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✗ ✓ ✗ ✓ ✓ ✓
Beneish M-Score
-2.85
Unlikely Manipulator
Ohlson O-Score
-7.09
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
AA+
Score: 94.7/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 0.94x
Accruals: 0.7%
The Altman-I Score is adapted for insurance companies, emphasizing return on equity, tangible net worth, and cash reserves alongside the standard equity and earnings components. ALL scores 11.39, placing it in the Safe Zone (safe > 3.0, distress < 1.5). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ALL scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ALL's score of -2.85 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ALL's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ALL receives an estimated rating of AA+ (score: 94.7/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ALL's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
4.41x
PEG
0.03x
P/S
0.83x
P/B
1.70x
P/FCF
5.03x
P/OCF
4.94x
EV/EBITDA
3.58x
EV/Revenue
0.92x
EV/EBIT
3.65x
EV/FCF
5.18x
Earnings Yield
21.59%
FCF Yield
19.87%
Shareholder Yield
5.91%
Graham Number
$387.70
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 4.4x earnings, ALL trades at a deep value multiple. An earnings yield of 21.6% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $387.70 per share, suggesting a potential 73% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.784
NI / EBT
×
Interest Burden
0.976
EBT / EBIT
×
EBIT Margin
0.251
EBIT / Rev
×
Asset Turnover
0.575
Rev / Assets
×
Equity Multiplier
4.169
Assets / Equity
=
ROE
46.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ALL's ROE of 46.1% is driven by financial leverage (equity multiplier: 4.17x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$1977.60
Price/Value
0.12x
Margin of Safety
87.97%
Premium
-87.97%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ALL's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $1977.60, ALL appears undervalued with a 88% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 4.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$223.74
Median 1Y
$245.12
5th Pctile
$150.01
95th Pctile
$399.46
Ann. Volatility
28.2%
Analyst Target
$267.71
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Thomas J. Wilson
Chair, President and Chief Executive Officer
$1,417,308 $11,899,608 $26,744,295
Mario Rizzo President,
Property-Liability
$875,000 $3,701,521 $9,326,860
John Dugenske President,
Investments and Corporate Strategy
$875,000 $3,146,346 $8,174,571
Jesse Merten Financial
Vice President and Chief Financial Officer
$805,096 $3,045,688 $7,712,339
Christine DeBiase President,
Vice President, Chief Legal Officer and General Counsel
$722,596 $1,827,444 $5,170,187

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
53,000
-3.6% YoY
Revenue / Employee
$1,253,962
Rev: $66,460,000,000
Profit / Employee
$194,000
NI: $10,282,000,000
SGA / Employee
$-566
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 12.6% 5.8% 14.6% 4.1% -0.9% -6.1% -11.2% -14.7% -12.2% -1.1% 7.5% 17.8% 23.8% 23.8% 19.9% 27.3% 34.6% 39.5% 45.3% 46.1% 46.12%
ROA 2.7% 1.4% 3.2% 0.9% -0.2% -1.3% -2.3% -2.7% -2.0% -0.2% 1.3% 2.9% 3.9% 4.3% 3.7% 5.2% 7.2% 8.9% 10.2% 11.1% 11.06%
ROIC 24.2% 18.2% 13.2% 4.1% -0.1% -7.1% -13.0% -15.6% -11.2% -1.4% 6.1% 14.6% 19.8% 18.9% 17.6% 26.8% 32.1% 31.6% 36.2% 37.9% 37.92%
ROCE 6.5% 6.8% 4.7% 1.5% 0.3% -1.5% -2.7% -3.1% -2.2% 0.0% 1.8% 3.8% 4.9% 5.5% 4.7% 6.6% 23.2% 27.8% 40.9% 32.9% 32.91%
Gross Margin 16.0% 12.4% 19.5% 6.8% 7.1% 10.8% 9.5% 0.7% 13.8% 25.8% 22.0% 16.2% 22.6% 30.1% 18.6% 24.4% 36.6% 53.0% 45.3% 34.7% 34.75%
Operating Margin 1.9% 12.6% 6.7% -10.9% -7.0% -3.1% -3.0% -12.6% -0.1% 12.4% 9.7% 2.8% 8.6% 15.0% 4.4% 16.3% 28.2% 29.6% 18.9% 22.8% 22.80%
Net Margin 4.5% 7.4% 5.5% -8.4% -5.1% -2.1% -2.3% -9.7% -0.0% 10.1% 8.1% 2.1% 7.2% 11.8% 3.7% 12.7% 22.0% 23.1% 14.5% 17.6% 17.60%
EBITDA Margin 4.5% 15.8% 9.3% -8.4% -4.9% -1.0% -1.0% -10.6% 1.7% 14.2% 11.2% 4.2% 10.1% 16.5% 5.8% 17.7% 29.5% 30.9% 19.4% 23.0% 23.02%
FCF Margin 10.6% 9.9% 7.8% 8.3% 9.6% 9.3% 9.5% 8.3% 6.7% 7.0% 8.7% 10.5% 13.3% 13.7% 13.9% 13.0% 13.0% 14.9% 17.2% 17.7% 17.70%
OCF Margin 11.3% 10.6% 8.7% 9.1% 10.4% 10.1% 10.2% 8.9% 7.2% 7.5% 9.1% 10.8% 13.6% 14.1% 14.3% 13.3% 13.3% 15.2% 17.4% 18.0% 18.02%
ROE 3Y Avg snapshot only 26.68%
ROE 5Y Avg snapshot only 13.64%
ROA 3Y Avg snapshot only 6.16%
ROIC 3Y Avg snapshot only 22.19%
ROIC Economic snapshot only 33.80%
Cash ROA snapshot only 9.99%
Cash ROIC snapshot only 35.15%
CROIC snapshot only 34.53%
NOPAT Margin snapshot only 19.45%
Pretax Margin snapshot only 24.55%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 9.55%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 10.04 19.30 9.80 31.86 -158.96 -25.79 -12.04 -10.36 -14.20 -189.34 33.00 13.66 11.74 10.89 13.52 9.17 6.79 5.36 4.48 4.63 4.413
P/S Ratio 0.70 0.64 0.75 0.68 0.64 0.66 0.53 0.50 0.50 0.63 0.77 0.69 0.80 0.80 0.84 0.81 0.86 0.83 0.81 0.89 0.832
P/B Ratio 1.28 1.23 1.54 1.59 1.75 1.91 1.57 1.75 1.91 2.00 2.39 2.23 2.38 2.37 2.48 2.22 2.07 1.80 1.72 1.83 1.700
P/FCF 6.57 6.47 9.53 8.13 6.72 7.11 5.57 6.09 7.51 8.99 8.80 6.62 6.04 5.83 6.09 6.26 6.59 5.58 4.72 5.03 5.033
P/OCF 6.14 6.03 8.58 7.42 6.17 6.53 5.18 5.66 7.01 8.42 8.42 6.39 5.87 5.69 5.92 6.11 6.45 5.45 4.65 4.94 4.944
EV/EBITDA 3.62 4.33 6.81 14.51 27.94 -55.45 -14.82 -12.31 -21.05 51.26 18.41 9.29 8.16 7.99 9.27 6.17 4.76 4.06 3.45 3.58 3.580
EV/Revenue 0.71 0.71 0.80 0.74 0.71 0.72 0.55 0.54 0.57 0.67 0.82 0.73 0.81 0.84 0.86 0.77 0.84 0.86 0.84 0.92 0.917
EV/EBIT 4.03 5.03 8.40 24.33 110.87 -24.24 -10.51 -9.33 -14.09 1215.25 24.75 10.67 9.00 8.71 10.22 6.61 4.99 4.21 3.54 3.65 3.645
EV/FCF 6.73 7.14 10.19 8.84 7.41 7.76 5.79 6.56 8.51 9.51 9.34 6.97 6.07 6.15 6.17 5.96 6.41 5.77 4.90 5.18 5.178
Earnings Yield 10.0% 5.2% 10.2% 3.1% -0.6% -3.9% -8.3% -9.6% -7.0% -0.5% 3.0% 7.3% 8.5% 9.2% 7.4% 10.9% 14.7% 18.7% 22.3% 21.6% 21.59%
FCF Yield 15.2% 15.5% 10.5% 12.3% 14.9% 14.1% 18.0% 16.4% 13.3% 11.1% 11.4% 15.1% 16.6% 17.2% 16.4% 16.0% 15.2% 17.9% 21.2% 19.9% 19.87%
PEG Ratio snapshot only 0.033
Price/Tangible Book snapshot only 2.016
EV/OCF snapshot only 5.087
EV/Gross Profit snapshot only 2.175
Acquirers Multiple snapshot only 3.692
Shareholder Yield snapshot only 5.91%
Graham Number snapshot only $387.70
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio — — — — — — — — — — — — — — — — 0.43 0.37 0.38 0.24 0.244
Quick Ratio — — — — — — — — — — — — — — — — 0.43 0.37 0.38 0.24 0.244
Debt/Equity 0.30 0.32 0.34 0.40 0.45 0.46 0.48 0.51 0.54 0.45 0.43 0.43 0.39 0.38 0.37 0.34 0.29 0.24 0.24 0.22 0.222
Net Debt/Equity 0.03 0.13 0.11 0.14 0.18 0.17 0.06 0.14 0.25 0.12 0.15 0.12 0.01 0.13 0.03 -0.11 -0.06 0.06 0.07 0.05 0.053
Debt/Assets 0.06 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.060
Debt/EBITDA 0.82 1.01 1.42 3.33 6.52 -12.10 -4.40 -3.35 -5.30 10.81 3.09 1.72 1.32 1.20 1.35 0.98 0.70 0.53 0.46 0.42 0.423
Net Debt/EBITDA 0.09 0.41 0.45 1.18 2.58 -4.64 -0.56 -0.89 -2.48 2.82 1.08 0.47 0.04 0.42 0.12 -0.31 -0.14 0.14 0.13 0.10 0.100
Interest Coverage 26.66 20.54 13.90 4.48 0.92 -4.49 -8.01 -8.87 -6.29 0.08 4.90 10.49 13.66 15.40 13.45 19.00 27.59 33.97 40.22 44.27 44.275
Equity Multiplier 4.99 3.95 4.19 4.79 5.53 5.60 5.70 6.48 6.93 5.82 5.65 5.83 5.45 5.21 5.22 4.83 4.38 3.91 3.92 3.70 3.702
Cash Ratio snapshot only 0.079
Debt Service Coverage snapshot only 45.079
Cash to Debt snapshot only 0.762
FCF to Debt snapshot only 1.635
Defensive Interval snapshot only 535.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.38 0.43 0.42 0.41 0.42 0.51 0.53 0.55 0.56 0.56 0.57 0.57 0.58 0.59 0.59 0.59 0.57 0.57 0.56 0.58 0.575
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 2.85 3.01 2.65 2.64 2.53 2.72 2.77 2.91 2.89 3.01 3.03 3.12 3.16 3.31 3.20 3.25 3.20 3.36 4.09 4.22 4.221
Payables Turnover — — — — — — — — — — — — — — — — — — — — —
DSO 128 121 138 139 144 134 132 126 126 121 121 117 116 110 114 112 114 109 89 86 86.5 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 —
Cash Conversion Cycle 128 121 138 139 144 134 132 126 126 121 121 117 116 110 114 112 114 109 89 86 —
Fixed Asset Turnover snapshot only 117.069
Cash Velocity snapshot only 12.113
Capital Intensity snapshot only 1.803
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 15.9% 12.2% 5.0% -1.2% -2.2% 4.7% 8.9% 14.1% 14.9% 12.1% 11.4% 10.9% 12.1% 12.2% 11.6% 9.8% 6.9% 4.6% 3.7% 5.4% 5.39%
Net Income -27.9% -71.3% -0.2% -75.1% -1.1% -1.8% -1.6% -3.6% -9.1% 85.5% 1.6% 2.2% 3.2% 25.8% 2.0% 92.0% 98.2% 1.2% 2.0% 1.3% 1.29%
EPS -24.0% -69.5% 8.6% -72.4% -1.1% -1.9% -1.7% -3.7% -9.3% 85.5% 1.6% 2.1% 3.1% 25.5% 2.0% 91.4% 99.3% 1.2% 2.1% 1.4% 1.36%
FCF 3.5% -7.9% -32.5% -24.3% -11.4% -1.5% 31.4% 13.3% -19.6% -15.7% 2.9% 40.6% 1.2% 1.2% 77.1% 36.4% 5.1% 13.3% 28.6% 43.4% 43.45%
EBITDA 35.4% -4.7% -45.9% -78.1% -87.4% -1.1% -1.3% -2.0% -2.2% 2.1% 2.3% 3.0% 5.1% 8.1% 1.3% 75.6% 90.0% 1.1% 1.7% 1.1% 1.15%
Op. Income 35.6% -11.0% -54.4% -88.5% -1.0% -1.3% -1.7% -4.1% -95.1% 81.1% 1.5% 2.1% 3.0% 17.6% 2.3% 97.0% 1.1% 1.3% 2.1% 1.4% 1.36%
OCF Growth snapshot only 42.62%
Asset Growth snapshot only 7.65%
Equity Growth snapshot only 40.30%
Debt Growth snapshot only -7.36%
Shares Change snapshot only -3.28%
Dividend Growth snapshot only 10.18%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 7.0% 6.6% 5.2% 3.9% 4.1% 4.2% 6.1% 8.0% 9.2% 9.6% 8.4% 7.7% 8.0% 9.6% 10.6% 11.6% 11.2% 9.6% 8.8% 8.7% 8.70%
Revenue 5Y 6.5% 5.7% 5.1% 4.5% 4.5% 5.2% 5.8% 6.3% 6.6% 7.3% 7.2% 7.3% 7.7% 7.3% 8.2% 8.9% 9.3% 9.1% 8.1% 7.7% 7.68%
EPS 3Y 0.6% -7.6% 17.0% -24.4% — — — — — — -24.8% -5.0% 11.3% 46.4% 5.3% 81.1% — — — — —
EPS 5Y 23.0% 1.9% 15.6% -12.5% — — — — — — -8.9% 6.0% 13.4% 3.2% 3.5% 8.9% 15.9% 16.5% 31.2% 31.1% 31.11%
Net Income 3Y -4.8% -13.1% 10.2% -29.4% — — — — — — -28.2% -9.0% 7.5% 42.9% 3.6% 79.8% — — — — —
Net Income 5Y 17.4% -3.2% 9.4% -17.6% — — — — — — -13.1% 1.2% 8.6% -0.8% -0.3% 5.3% 12.1% 13.0% 27.2% 27.0% 27.05%
EBITDA 3Y 22.1% 27.2% 10.0% -18.5% -34.9% — — — — -55.3% -37.2% -24.6% -14.2% -5.1% 2.1% 51.0% 1.1% — — — —
EBITDA 5Y 27.4% 18.0% 6.3% -12.4% -24.2% — — — — -28.1% -9.4% 1.2% 6.7% -1.0% -1.6% 4.0% 10.2% 11.2% 9.6% 10.1% 10.12%
Gross Profit 3Y 12.4% 8.0% -1.2% -13.5% -18.9% -23.8% -28.7% -34.3% -29.0% -20.7% -16.9% -10.0% -3.3% 7.8% 15.3% 34.4% 49.4% 58.6% 81.3% 97.9% 97.90%
Gross Profit 5Y 17.8% 10.0% 2.6% -6.3% -10.7% -10.9% -15.1% -18.2% -14.3% -4.8% -0.9% 3.1% 5.5% 3.0% 2.8% 3.4% 6.2% 8.9% 10.8% 12.8% 12.84%
Op. Income 3Y 23.0% 29.4% 8.2% -31.9% — — — — — — -45.2% -27.4% -15.0% -3.7% 6.0% 87.3% — — — — —
Op. Income 5Y 30.4% 18.5% 4.3% -22.2% — — — — — — -14.5% 1.0% 8.0% -1.1% -1.8% 4.7% 11.6% 12.7% 11.1% 12.2% 12.19%
FCF 3Y 3.9% -0.9% -9.0% -6.6% -1.9% 0.0% -0.7% -6.9% -9.7% -8.6% -3.0% 6.4% 16.5% 22.3% 33.8% 29.5% 23.3% 28.1% 32.8% 40.1% 40.11%
FCF 5Y 8.9% 5.3% -0.3% 1.5% 2.2% 3.2% 5.3% -1.4% -4.4% -4.2% 0.4% 5.3% 11.0% 13.2% 12.3% 9.1% 11.4% 13.8% 15.8% 18.7% 18.73%
OCF 3Y 4.2% -0.4% -7.5% -5.8% -1.5% -0.1% -0.9% -7.0% -9.8% -8.3% -3.3% 5.4% 14.9% 20.4% 30.4% 26.6% 20.7% 25.4% 30.3% 37.6% 37.60%
OCF 5Y 8.7% 5.1% 0.1% 1.6% 2.4% 3.5% 5.3% -1.1% -4.2% -4.0% 0.1% 4.7% 10.0% 11.7% 11.1% 8.0% 10.3% 13.0% 14.9% 17.7% 17.65%
Assets 3Y 5.2% -4.0% -5.7% -6.6% -6.9% -6.5% -5.0% -6.1% -6.2% -6.4% -6.8% -6.5% -5.2% 3.9% 5.8% 6.3% 7.2% 6.9% 7.6% 7.5% 7.47%
Assets 5Y 4.2% -1.7% -2.5% -2.8% -3.0% -2.7% -2.5% -2.4% -2.4% -1.6% -1.9% -1.8% -1.2% -1.4% -0.2% -0.9% -0.4% -1.0% -0.9% -1.2% -1.22%
Equity 3Y 4.2% 5.7% -0.3% -6.3% -12.2% -12.4% -10.2% -16.8% -18.8% -16.2% -11.4% -13.0% -7.9% -5.2% -1.7% 6.1% 15.9% 20.5% 21.8% 29.5% 29.50%
Book Value 3Y 10.1% 12.4% 5.9% 0.4% -5.7% -6.0% -4.0% -11.5% -13.7% -11.9% -7.2% -9.2% -4.6% -2.9% -0.0% 6.9% 16.2% 20.5% 21.9% 30.1% 30.08%
Dividend 3Y 11.8% 15.6% 17.8% 14.8% 11.4% 8.4% 5.6% 5.5% 5.5% 5.2% 5.4% 5.4% 5.6% 4.0% 3.2% 2.5% 2.0% 2.2% 2.5% 2.6% 2.60%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.89 0.88 1.00 0.92 0.85 0.89 0.97 0.90 0.87 0.94 0.94 0.89 0.88 0.89 0.94 0.95 0.97 0.98 0.98 0.98 0.981
Earnings Stability 0.47 0.07 0.46 0.05 0.21 0.28 0.35 0.56 0.66 0.49 0.33 0.23 0.11 0.15 0.08 0.00 0.08 0.18 0.28 0.44 0.441
Margin Stability 0.79 0.79 0.76 0.69 0.67 0.66 0.57 0.49 0.50 0.56 0.52 0.49 0.53 0.62 0.61 0.51 0.51 0.52 0.46 0.47 0.467
Rev. Growth Consistency 0.50 0.50 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.89 0.50 1.00 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.68 0.00 1.00 0.00 — — — — — — — — — — 0.00 0.37 0.34 0.25 0.00 0.22 0.217
ROE Trend -0.01 -0.12 0.00 -0.10 -0.16 -0.20 -0.28 -0.26 -0.19 -0.01 0.06 0.22 0.28 0.26 0.21 0.25 0.27 0.23 0.26 0.19 0.192
Gross Margin Trend 0.02 -0.07 -0.12 -0.19 -0.20 -0.18 -0.19 -0.17 -0.12 -0.05 0.02 0.09 0.12 0.11 0.10 0.11 0.12 0.15 0.21 0.20 0.205
FCF Margin Trend -0.01 -0.01 -0.04 -0.04 -0.02 -0.02 -0.01 -0.01 -0.03 -0.03 0.00 0.02 0.05 0.06 0.05 0.04 0.03 0.05 0.06 0.06 0.060
Sustainable Growth Rate 9.2% 2.2% 10.3% -0.2% — — — — — — 1.7% 11.6% 17.8% 18.3% 14.5% 22.1% 29.9% 35.1% 40.9% 42.0% 42.01%
Internal Growth Rate 2.0% 0.5% 2.3% — — — — — — — 0.3% 1.9% 3.0% 3.5% 2.8% 4.4% 6.6% 8.6% 10.1% 11.2% 11.21%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.63 3.20 1.14 4.30 -25.75 -3.95 -2.32 -1.83 -2.03 -22.49 3.92 2.14 2.00 1.91 2.28 1.50 1.05 0.98 0.96 0.94 0.937
FCF/OCF 0.94 0.93 0.90 0.91 0.92 0.92 0.93 0.93 0.93 0.94 0.96 0.97 0.97 0.98 0.97 0.98 0.98 0.98 0.98 0.98 0.982
FCF/Net Income snapshot only 0.920
OCF/EBITDA snapshot only 0.704
CapEx/Revenue 0.7% 0.7% 0.9% 0.8% 0.9% 0.8% 0.7% 0.6% 0.5% 0.5% 0.4% 0.4% 0.4% 0.3% 0.4% 0.3% 0.3% 0.3% 0.3% 0.3% 0.32%
CapEx/Depreciation snapshot only 0.696
Accruals Ratio -0.02 -0.03 -0.00 -0.03 -0.05 -0.07 -0.08 -0.08 -0.06 -0.04 -0.04 -0.03 -0.04 -0.04 -0.05 -0.03 -0.00 0.00 0.00 0.01 0.007
Sloan Accruals snapshot only -0.716
Cash Flow Adequacy snapshot only 8.875
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.7% 3.2% 3.0% 3.3% 3.4% 3.1% 3.7% 3.8% 3.7% 2.9% 2.3% 2.5% 2.2% 2.1% 2.0% 2.1% 2.0% 2.1% 2.1% 1.9% 1.90%
Dividend/Share $3.13 $3.46 $3.78 $3.84 $3.87 $3.90 $3.89 $3.90 $3.88 $3.90 $3.92 $3.95 $4.01 $4.02 $4.07 $4.15 $4.25 $4.36 $4.46 $4.57 $4.24
Payout Ratio 27.3% 62.5% 29.2% 1.0% — — — — — — 77.3% 34.8% 25.4% 23.1% 27.0% 19.1% 13.5% 11.2% 9.6% 8.9% 8.90%
FCF Payout Ratio 17.9% 20.9% 28.4% 26.8% 22.5% 21.9% 20.8% 23.0% 27.4% 26.1% 20.6% 16.9% 13.1% 12.4% 12.2% 13.0% 13.1% 11.7% 10.1% 9.7% 9.67%
Total Payout Ratio 1.1% 2.9% 1.3% 4.8% — — — — — — 1.3% 35.7% 25.4% 23.2% 29.5% 26.7% 23.1% 23.2% 24.0% 27.4% 27.38%
Div. Increase Streak 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1
Chowder Number 0.21 0.32 0.40 0.26 0.15 0.06 0.00 0.01 0.02 0.03 0.04 0.06 0.08 0.07 0.06 0.07 0.07 0.09 0.09 0.08 0.085
Buyback Yield 7.9% 11.6% 10.2% 11.8% 9.7% 7.5% 6.8% 7.1% 4.6% 2.6% 1.7% 0.1% 0.0% 0.0% 0.2% 0.8% 1.4% 2.2% 3.2% 4.0% 3.99%
Net Buyback Yield 7.8% 11.5% 10.2% 11.7% 9.7% 7.5% 6.8% 4.9% 2.5% 0.7% 0.1% -0.3% -0.4% -0.3% 0.1% 0.7% 1.4% 2.2% 3.2% 3.9% 3.91%
Total Shareholder Return 10.5% 14.7% 13.2% 15.0% 13.1% 10.6% 10.6% 8.7% 6.1% 3.6% 2.4% 2.3% 1.8% 1.8% 2.1% 2.8% 3.4% 4.3% 5.3% 5.8% 5.83%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.41 0.25 0.86 0.90 7.22 0.70 0.75 0.75 0.76 0.54 0.89 0.82 0.82 0.81 0.81 0.80 0.78 0.78 0.78 0.78 0.784
Interest Burden (EBT/EBIT) 0.96 0.95 0.93 0.78 -0.09 1.22 1.12 1.11 1.16 -11.23 0.80 0.90 0.93 0.94 0.93 0.95 0.96 0.97 0.97 0.98 0.976
EBIT Margin 0.18 0.14 0.10 0.03 0.01 -0.03 -0.05 -0.06 -0.04 0.00 0.03 0.07 0.09 0.10 0.08 0.12 0.17 0.20 0.24 0.25 0.251
Asset Turnover 0.38 0.43 0.42 0.41 0.42 0.51 0.53 0.55 0.56 0.56 0.57 0.57 0.58 0.59 0.59 0.59 0.57 0.57 0.56 0.58 0.575
Equity Multiplier 4.74 4.07 4.54 4.74 5.21 4.63 4.83 5.52 6.16 5.71 5.67 6.12 6.06 5.48 5.42 5.26 4.84 4.45 4.46 4.17 4.169
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $11.43 $5.53 $12.92 $3.66 $-0.73 $-4.90 $-8.64 $-9.96 $-7.49 $-0.71 $5.07 $11.36 $15.78 $17.37 $15.10 $21.73 $31.45 $38.84 $46.25 $51.37 $51.37
Book Value/Share $89.72 $87.12 $82.37 $73.47 $65.77 $66.14 $66.39 $59.09 $55.74 $67.13 $69.94 $69.61 $77.90 $79.80 $82.36 $89.66 $103.25 $115.64 $120.36 $130.06 $131.55
Tangible Book/Share $78.35 $70.09 $69.96 $60.70 $52.74 $48.45 $53.10 $45.75 $42.36 $50.25 $56.80 $56.50 $65.94 $64.92 $70.72 $78.02 $68.66 $78.47 $108.49 $118.02 $118.02
Revenue/Share $165.06 $166.83 $169.65 $172.49 $179.02 $190.94 $197.61 $205.15 $211.05 $213.79 $217.68 $223.76 $231.15 $236.38 $241.70 $245.05 $248.54 $251.08 $255.67 $267.03 $270.27
FCF/Share $17.47 $16.51 $13.29 $14.35 $17.16 $17.78 $18.68 $16.96 $14.17 $14.96 $19.00 $23.44 $30.67 $32.46 $33.49 $31.87 $32.42 $37.33 $43.91 $47.28 $47.85
OCF/Share $18.68 $17.70 $14.76 $15.72 $18.69 $19.37 $20.08 $18.23 $15.18 $15.97 $19.86 $24.27 $31.53 $33.24 $34.46 $32.64 $33.13 $38.19 $44.58 $48.12 $48.71
Cash/Share $23.89 $16.51 $19.43 $18.81 $17.92 $18.57 $28.02 $22.22 $16.15 $22.16 $19.39 $22.04 $29.14 $19.51 $27.56 $39.70 $36.31 $21.02 $20.57 $22.05 $22.31
EBITDA/Share $32.54 $27.21 $19.89 $8.75 $4.55 $-2.49 $-7.29 $-9.04 $-5.73 $2.78 $9.65 $17.58 $22.81 $24.99 $22.31 $30.77 $43.61 $53.03 $62.32 $68.38 $68.38
Debt/Share $26.79 $27.60 $28.29 $29.11 $29.65 $30.12 $32.08 $30.27 $30.35 $30.00 $29.79 $30.26 $30.16 $30.09 $30.19 $30.19 $30.36 $28.30 $28.53 $28.92 $28.92
Net Debt/Share $2.89 $11.09 $8.87 $10.30 $11.73 $11.55 $4.05 $8.05 $14.20 $7.84 $10.39 $8.22 $1.02 $10.58 $2.63 $-9.51 $-5.95 $7.27 $7.96 $6.87 $6.87
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman-I Score — — — — — — — — — — — — — — — — — — — — 11.392
Altman Z-Prime snapshot only 0.556
Piotroski F-Score 5 5 6 5 4 4 4 5 6 6 7 7 7 7 6 7 8 7 6 7 7
Beneish M-Score -1.68 -1.27 -2.08 -0.53 -2.35 -2.48 -2.11 1.97 -3.10 -2.49 -2.73 -2.93 -2.63 -2.66 3.89 -2.54 -1.75 -2.45 -12.30 -2.85 -2.854
Ohlson O-Score snapshot only -7.092
Net-Net WC snapshot only $-283.68
EVA snapshot only $9906124408.34
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA+
Credit Score 93.39 89.93 80.62 68.22 57.38 63.06 62.87 62.00 58.16 50.55 69.47 83.57 83.55 87.07 85.16 92.81 93.55 93.15 92.61 94.71 94.706
Credit Grade snapshot only 2
Credit Trend snapshot only 1.896
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 83
Sector Credit Rank snapshot only 96

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms